Pharmaterials has exclusive worldwide rights to a multidose blister dry powder inhaler.
Having materials science, formulation development, analytical development, in house and public access inhalers and GMP manuafcture all on site make Pharmaterials the obvious choice for DPI development. The highest standards of service, staff and equipment in all areas make us the obvious partner for your needs.
Contact us.
For further information click here |